256 related articles for article (PubMed ID: 19924834)
1. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
[TBL] [Abstract][Full Text] [Related]
2. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
[TBL] [Abstract][Full Text] [Related]
3. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
4. Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer.
Li Q; Wang K; Su C; Fang J
Technol Cancer Res Treat; 2017 Aug; 16(4):440-445. PubMed ID: 27760866
[TBL] [Abstract][Full Text] [Related]
5. Analysis of colorectal cancer glyco-secretome identifies laminin β-1 (LAMB1) as a potential serological biomarker for colorectal cancer.
Lin Q; Lim HS; Lin HL; Tan HT; Lim TK; Cheong WK; Cheah PY; Tang CL; Chow PK; Chung MC
Proteomics; 2015 Nov; 15(22):3905-20. PubMed ID: 26359947
[TBL] [Abstract][Full Text] [Related]
6. Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.
Okamura T; Shimada Y; Nogami H; Kameyama H; Kobayashi T; Kosugi S; Wakai T; Ajioka Y
Dis Colon Rectum; 2016 May; 59(5):396-402. PubMed ID: 27050601
[TBL] [Abstract][Full Text] [Related]
7. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
[TBL] [Abstract][Full Text] [Related]
8. [Monitoring changes of serum protein markers in metastatic colorectal carcinoma model].
Li ZG; Zhao L; Liu L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):48-52. PubMed ID: 17374239
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
[TBL] [Abstract][Full Text] [Related]
10. Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.
Lin PC; Yang YF; Tyan YC; Hsiao ES; Chu PC; Lee CT; Lee JC; Chen YM; Liao PC
PLoS One; 2016; 11(7):e0158844. PubMed ID: 27383761
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
[TBL] [Abstract][Full Text] [Related]
12. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum angiopoietin-like protein 2 correlates with the metastatic properties of colorectal cancer: a serum biomarker for early diagnosis and recurrence.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Kawamura M; Kawamoto A; Okugawa Y; Saigusa S; Hiro J; Inoue Y; Mohri Y; Goel A; Kusunoki M
Clin Cancer Res; 2014 Dec; 20(23):6175-86. PubMed ID: 25294915
[TBL] [Abstract][Full Text] [Related]
14. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
[TBL] [Abstract][Full Text] [Related]
15. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
[TBL] [Abstract][Full Text] [Related]
16. Direct serum assay for cell-free bmi-1 mRNA and its potential diagnostic and prognostic value for colorectal cancer.
Zhang X; Yang X; Zhang Y; Liu X; Zheng G; Yang Y; Wang L; Du L; Wang C
Clin Cancer Res; 2015 Mar; 21(5):1225-33. PubMed ID: 25547677
[TBL] [Abstract][Full Text] [Related]
17. Colorectal Cancer Cell Line SW480 and SW620 Released Extravascular Vesicles: Focus on Hypoxia-induced Surface Proteome Changes.
Nakurte I; Jekabsons K; Rembergs R; Zandberga E; Abols A; Linē A; Muceniece R
Anticancer Res; 2018 Nov; 38(11):6133-6138. PubMed ID: 30396929
[TBL] [Abstract][Full Text] [Related]
18. Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.
Meding S; Balluff B; Elsner M; Schöne C; Rauser S; Nitsche U; Maak M; Schäfer A; Hauck SM; Ueffing M; Langer R; Höfler H; Friess H; Rosenberg R; Walch A
J Pathol; 2012 Dec; 228(4):459-70. PubMed ID: 22430872
[TBL] [Abstract][Full Text] [Related]
19. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
[TBL] [Abstract][Full Text] [Related]
20. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]